newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Conference Call to Discuss AAIC Abstract Findings

NEW YORK, July 21, 2021 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that it will hold a conference call for investors to discuss